A Bill to make provision about the evaluation of methods of testing the safety of medicines; and for connected purposes.
The Bill proposes the establishment of a Medicines Safety Evaluation Panel to compare the effectiveness of human biology-based tests and animal-based tests in assessing the safety of medicines and drugs. The panel would be required to report within two years and would have full access to all relevant records held by the Medicines and Healthcare Products Regulatory Agency.
House of Commons
26 October 2009
May contain errors — check source documents for definitive information.
This bill would create a Medicines Safety Evaluation Panel to compare different ways of testing medicine safety—specifically human biology-based tests versus animal-based tests. It requires the panel to report within two years and to have full access to relevant records held by the MHRA, with the aim of guiding how safety testing is evaluated in future regulation.
The Bill is currently at the second Reading stage in the House of Commons (originating in the Commons).
Generated 21 February 2026
26 Jan 2009
This Bill was presented to Parliament on 26 January. This is known as First Reading and there was no debate on the Bill at this stage.
This Bill was on the Order Paper for a Second Reading on several Fridays before being dropped by its sponsor, Dr Ian Gibson.
No recorded votes for this bill yet.
